However, while our findings establish CAP as a TRPV1-dependent hepatoprotective agent in diet-induced obesity, it remains unclear whether these effects are mediated solely through systemic metabolic improvements or whether CAP also acts directly on the liver, independent of weight reduction. The gene discussed is TRPV1; the disease is obesity due to melanocortin 4 receptor deficiency.